MA24704A1 - NOVEL PAROXETINE FORMULATIONS AND PROCESS FOR THEIR PREPARATION - Google Patents
NOVEL PAROXETINE FORMULATIONS AND PROCESS FOR THEIR PREPARATIONInfo
- Publication number
- MA24704A1 MA24704A1 MA25357A MA25357A MA24704A1 MA 24704 A1 MA24704 A1 MA 24704A1 MA 25357 A MA25357 A MA 25357A MA 25357 A MA25357 A MA 25357A MA 24704 A1 MA24704 A1 MA 24704A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- formulations
- novel
- paroxetine
- paroxetine formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'INVENTION CONCERNE DES FORMULATIONS PHARMACEUTIQUES DE PAROXÉTINE DANS LESQUELLES LA PAROXÉTINE EST EN SOLUTION DANS UN VÉHICULE SOLIDE, SEMI-SOLIDE OU LIQUIDE. ELLE COMPREND ÉGALEMENT UN PROCÉDÉ POUR LA PRÉPARATION DE CES FORMULATIONS. APPLICATION : TRAITEMENT DE DIVERSES AFFECTIONS CHEZ UN MAMMIFèRE, Y COMPRIS L'HOMME THE INVENTION RELATES TO PHARMACEUTICAL FORMULATIONS OF PAROXETINE IN WHICH PAROXETINE IS IN SOLUTION IN A SOLID, SEMI-SOLID OR LIQUID VEHICLE. IT ALSO INCLUDES A PROCESS FOR THE PREPARATION OF THESE FORMULATIONS. APPLICATION: TREATMENT OF VARIOUS CONDITIONS IN A MAMMAL, INCLUDING MAN
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9724544.3A GB9724544D0 (en) | 1997-11-21 | 1997-11-21 | Novel Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA24704A1 true MA24704A1 (en) | 1999-07-01 |
Family
ID=10822374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25357A MA24704A1 (en) | 1997-11-21 | 1998-11-19 | NOVEL PAROXETINE FORMULATIONS AND PROCESS FOR THEIR PREPARATION |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1033986A1 (en) |
JP (1) | JP2001523718A (en) |
KR (1) | KR20010032320A (en) |
CN (1) | CN1279608A (en) |
AP (1) | AP2000001821A0 (en) |
AR (1) | AR015485A1 (en) |
AU (1) | AU1168099A (en) |
BG (1) | BG104527A (en) |
BR (1) | BR9814220A (en) |
CO (1) | CO4970832A1 (en) |
DZ (1) | DZ2658A1 (en) |
EA (1) | EA200000552A1 (en) |
GB (1) | GB9724544D0 (en) |
HU (1) | HUP0100580A3 (en) |
IL (1) | IL136106A0 (en) |
MA (1) | MA24704A1 (en) |
NO (1) | NO20002590L (en) |
OA (1) | OA11385A (en) |
PE (1) | PE20000381A1 (en) |
PL (1) | PL340555A1 (en) |
SK (1) | SK7342000A3 (en) |
TR (1) | TR200001423T2 (en) |
WO (1) | WO1999026625A1 (en) |
ZA (1) | ZA9810637B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810180D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulation |
AU3810100A (en) | 1999-03-12 | 2000-10-04 | Basf Aktiengesellschaft | Stable pharmaceutical application form for paroxetin anhydrate |
AU5535900A (en) | 1999-07-01 | 2001-01-22 | Italfarmaco S.P.A. | Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
DE19930454A1 (en) * | 1999-07-02 | 2001-01-04 | Knoll Ag | Solid paroxetine-containing preparations |
US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
EP1455763B1 (en) * | 2001-12-21 | 2007-10-03 | Supernus Pharmaceuticals, Inc. | Oral capsule formulation with increased physical stability |
SE0200475D0 (en) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral pharmaceutical preparation |
WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
JP2013512948A (en) * | 2009-12-08 | 2013-04-18 | イル・ファ・カンパニー・リミテッド | Solid dispersion comprising 20-O-β-D-glucopyranosyl-20 (S) -protopanaxadiol |
GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
CN103961333B (en) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | Paroxetine mesylate capsule and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3768536B2 (en) * | 1995-04-03 | 2006-04-19 | アボツト・ラボラトリーズ | Homogeneous mixture of low-melting drugs and additives for controlled release |
TR199901622T2 (en) * | 1997-01-15 | 1999-09-21 | Smithkline Beecham Plc | Paroxetine compositions. |
-
1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
-
1998
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/en unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 IL IL13610698A patent/IL136106A0/en unknown
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/en not_active Application Discontinuation
- 1998-11-18 CN CN98811404A patent/CN1279608A/en active Pending
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/en not_active Application Discontinuation
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/en active Pending
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/en not_active Application Discontinuation
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/en unknown
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/en unknown
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/en not_active Application Discontinuation
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/en active
- 1998-11-18 PL PL98340555A patent/PL340555A1/en unknown
- 1998-11-18 EA EA200000552A patent/EA200000552A1/en unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/en not_active Withdrawn
- 1998-11-19 MA MA25357A patent/MA24704A1/en unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/en unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/en unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/en unknown
-
2000
- 2000-05-19 NO NO20002590A patent/NO20002590L/en not_active Application Discontinuation
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-06-13 BG BG104527A patent/BG104527A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE20000381A1 (en) | 2000-05-07 |
EA200000552A1 (en) | 2000-10-30 |
IL136106A0 (en) | 2001-05-20 |
EP1033986A1 (en) | 2000-09-13 |
SK7342000A3 (en) | 2000-12-11 |
ZA9810637B (en) | 2000-05-22 |
AU1168099A (en) | 1999-06-15 |
AR015485A1 (en) | 2001-05-02 |
GB9724544D0 (en) | 1998-01-21 |
BG104527A (en) | 2001-04-30 |
BR9814220A (en) | 2001-12-26 |
HUP0100580A2 (en) | 2002-04-29 |
TR200001423T2 (en) | 2000-10-23 |
NO20002590L (en) | 2000-07-19 |
WO1999026625A1 (en) | 1999-06-03 |
CO4970832A1 (en) | 2000-11-07 |
JP2001523718A (en) | 2001-11-27 |
AP2000001821A0 (en) | 2000-06-30 |
DZ2658A1 (en) | 2003-03-22 |
CN1279608A (en) | 2001-01-10 |
OA11385A (en) | 2004-01-27 |
PL340555A1 (en) | 2001-02-12 |
KR20010032320A (en) | 2001-04-16 |
NO20002590D0 (en) | 2000-05-19 |
HUP0100580A3 (en) | 2002-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26723A1 (en) | NOVEL OXAMIC ACIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN98155A1 (en) | COMBINATIONS OF PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN AND ANTIHYPERTENSITIVE AGENTS, AND PROCESS FOR THEIR PREPARATION | |
CA2330500A1 (en) | Pharmaceutical compositions capable of being gelled | |
TNSN97110A1 (en) | DERIVATIVES OF 2- (2-OXO-ETHYLIDENE) -IMIDAZOLIDINE-4-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
EP1014996A4 (en) | Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses | |
TNSN96172A1 (en) | HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
TNSN98156A1 (en) | PHARMACEUTICAL COMBINATIONS OF AMLODIPINE AND ATORVASTATIN AND PROCESS FOR THEIR PREPARATION | |
MA26702A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MIGRAINE, AND METHOD FOR THEIR PREPARATION | |
TNSN99253A1 (en) | CHEMICAL COMPOUNDS NOVEL MODULATORS OF CCR5, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
MA26718A1 (en) | NEW HETEROARYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2364030A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON ANTHOCYANIDINES AND PROCESS FOR THEIR PREPARATION | |
DZ2666A1 (en) | Hydroxamic acid derivatives pharmaceutical compositions containing them and process for their preparation. | |
TNSN96107A1 (en) | SUBSTITUTED BENZYLAMINOPIPERIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DZ2410A1 (en) | Arylsulfonylaminohydroxamic acid derivatives process for their preparation and pharmaceutical compositions | |
TNSN97087A1 (en) | NOVEL 4 (3H) -QUINAZOLINONES 2,3-DISUBSTITUTED, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA24729A1 (en) | NEW MACROLIDES. | |
FR2635265B1 (en) | INTRAVENOUS PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN AS ACTIVE INGREDIENT AND PROCESS FOR THE PREPARATION THEREOF | |
MA26733A1 (en) | NOVEL ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA24704A1 (en) | NOVEL PAROXETINE FORMULATIONS AND PROCESS FOR THEIR PREPARATION | |
TNSN00235A1 (en) | NEW HETEROCYCLO-ALKYLSULFONYLPYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | |
MA26739A1 (en) | MUTUAL SALT OF AMLODIPINE AND ATORVASTATIN, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2378523A1 (en) | ACNE TREATMENT MEDICINE | |
TNSN98158A1 (en) | PHARMACEUTICAL COMBINATIONS OF AMLODIPINE AND A STATIN, AND PROCESS FOR THEIR PREPARATION | |
MA26741A1 (en) | NEW ZIPRASIDONE SUSPENSIONS AND PROCESS FOR THEIR PREPARATION. | |
TNSN98185A1 (en) | NOVEL ISOQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |